Have the COVID-19 vaccines been tested on autistic young adults or young adults with a seizure disorder?

The COVID-19 vaccine has been approved through an Emergency Use Authorization (EUA). The Food and Drug Administration (FDA) has determined that the Pfizer COVID-19 vaccine meets the required safety and effectiveness standards. PharmScript will continue to follow the CDC’s Guidance for Immunization Services. There have not been unique studies in different populations, such as autistic young adults or young adults with seizure disorders.